5 research outputs found

    Capsaicin Entrapment in Metal-Organic Framework Material Derived from γ-Cyclodextrin

    No full text
    Capsaicin, a pungent molecule from red chilli is known for its therapeutic benefits. However, poor aqueous solubility coupled with inherent pungency has limited its applications. We envisaged, encapsulation of capsaicin in biocompatible MOF material derived from γ-cyclodextrin (γ-CD) to overcome solubility and pungency attributes. Encapsulation of capsaicin was accomplished via crystal growth achieved by vapour diffusion of ethanol to synthesis solution consisting of γ-CD, KOH and capsaicin.The accomplished MOF Caps@γ-CDMOF was thoroughly characterized in solid state by powder X-ray diffraction (PXRD), IR, DSC, SEM and in solution by UV, fluorescence, NMR spectroscopic techniques. The encapsulation of capsaicin was found to be slightly higher than 3:1 (γ-CD: capsaicin ratio) in Caps@γ-CDMOF.</p

    Flavone-based dual PARP-Tubulin inhibitor manifesting efficacy against endometrial cancer

    No full text
    AbstractStructural tailoring of the flavone framework (position 7) via organopalladium-catalyzed C–C bond formation was attempted in this study. The impact of substituents with varied electronic effects (phenyl ring, position 2 of the benzopyran scaffold) on the antitumor properties was also assessed. Resultantly, the efforts yielded a furyl arm bearing benzopyran possessing a 4-fluoro phenyl ring (position 2) (14) that manifested a magnificent antitumor profile against the Ishikawa cell lines mediated through dual inhibition of PARP and tubulin [(IC50 (PARP1) = 74 nM, IC50 (PARP2) = 109 nM) and tubulin (IC50 = 1.4 µM)]. Further investigations confirmed the ability of 14 to induce apoptosis as well as autophagy and cause cell cycle arrest at the G2/M phase. Overall, the outcome of the study culminated in a tractable dual PARP-tubulin inhibitor endowed with an impressive activity profile against endometrial cancer

    Silver nanoparticles as antimicrobial therapeutics: current perspectives and future challenges

    No full text
    corecore